Other reported body composition changes related to GLP-1 agonists include sonographic evidence of decreased peri-umbilical fat, sub-xiphoid fat, peri-renal fat, pre-aortic fat, and epicardial fat [12]
In this study, the animals received the GLP-1A exenatide (0.5 1 g.kg 1 BID) for 12 weeks, but the treatment did not resulted in differences in total weight, percentage of body fat, glycemia, leptin, adiponectin, glucagon and in glucose and insulin tolerance tests (GTT and ITT) (Hoelmkjaer et al., 2016)
Thats where youll see the greatest change the most quickly
What's actually been getting in the way
Antmen FM, Fedaioglu Z, Acar D, Sayar AK, Yavuz IE, Ada E, Karakose B, Rzayeva L, Demircan S, Kardouh F, Senay S, Kolgazi M, Suyen G, Oz-Arslan D (2024) Exploring Liraglutide in Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy Model in Rats: Impact on Inflammation, Mitochondrial Function, and Behavior